메뉴 건너뛰기
EMBO Reports
Volumn 12, Issue 8, 2011, Pages 769-771
The fourth front against cancer. the first clinical trials to test engineered viruses that attack tumour cells have yielded promising results for future cancer therapies

(1)  Hunter, Philip a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

JX 594; ONCOLYTIC VIRUS; ONCOVEX; REOLYSIN; UNCLASSIFIED DRUG;
EID: 79961056795     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2011.138     Document Type: Article
Times cited : (4)
References (3)
  • 1
    • 35548988475 scopus 로고    scopus 로고
    • Carboxypeptidase G2-based gene-directed enzyme-prodrug therapy: A new weapon in the GDEPT armoury
    • DOI 10.1038/nrc2247, PII NRC2247
    • Hedley D, Ogilvie L, Springer C (2007) Carboxypeptidase C2-based gene-directed enzyme-prodrug therapy: a new weapon in the CDEPT armoury. Nat Rev Cancer 7:870-879 (Pubitemid 350010854)
    • (2007) Nature Reviews Cancer , vol.7 , Issue.11 , pp. 870-879
    • Hedley, D.1    Ogilvie, L.2    Springer, C.3
  • 2
    • 67349247048 scopus 로고    scopus 로고
    • Oncolytic reovirus effectively targets breast cancer stem cells
    • Marcato P, Dean CA, Ciacomantonio CA, Lee PWK (2009) Oncolytic reovirus effectively targets breast cancer stem cells. Mol Therapy 17:972-979
    • (2009) Mol Therapy , vol.17 , pp. 972-979
    • Marcato, P.1    Dean, C.A.2    Ciacomantonio, C.A.3    Lee, P.W.K.4
  • 3
    • 33646413672 scopus 로고    scopus 로고
    • The global health burden of infection-associated cancers in the year2002
    • Parkin DM (2006) The global health burden of infection-associated cancers in the year2002. Int J Cancer 118:3030-3044
    • (2006) Int J Cancer , vol.118 , pp. 3030-3044
    • Parkin, D.M.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.